Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?

Group 1 - Arcturus Therapeutics Holdings Inc. (ARCT) has reached a key level of support, with a recent "golden cross" occurring as its 50-day simple moving average crossed above its 200-day simple moving average, indicating a potential bullish breakout [1] - The golden cross pattern consists of three stages: a downtrend that bottoms out, the shorter moving average crossing above the longer moving average, and a subsequent upward price movement [2] - ARCT shares have increased by 38.3% over the past four weeks, and the company holds a 3 (Hold) rating on the Zacks Rank, suggesting a potential for further breakout [3] Group 2 - There have been four upward changes in ARCT's earnings expectations for the current quarter over the past 60 days, with no downward changes, indicating a positive trend in earnings estimates [3] - The combination of rising earnings estimates and positive technical indicators suggests that investors may want to monitor ARCT for potential gains in the near future [4]